Comparative Bioavailability Between Two Tramadol Formulations: Study of the Better Controlled Release of a New 200 mg Once A Day (OAD) Formulation Versus Zytram® 200 mg
Clinical trial NCT00911742 · COMPLETED
Trial details
- NCT number
- NCT00911742
- Sponsor
- Labopharm Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2004-03-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.